TY - JOUR T1 - Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach. AU - Rasool,Muhammad Fawad, AU - Khalid,Ramsha, AU - Imran,Imran, AU - Majeed,Abdul, AU - Saeed,Hamid, AU - Alasmari,Fawaz, AU - Alanazi,Mohammed Mufadhe, AU - Alqahtani,Faleh, Y1 - 2020/05/11/ PY - 2020/02/18/received PY - 2020/04/20/accepted PY - 2020/5/13/pubmed PY - 2021/9/9/medline PY - 2020/5/13/entrez SP - 570 EP - 579 JF - Drug metabolism and disposition: the biological fate of chemicals JO - Drug Metab Dispos VL - 48 IS - 7 N2 - Theophylline is commonly used for the treatment of asthma and has a low hepatic clearance. The changes in plasma albumin concentration occurring in asthma may affect the exposure of theophylline. The aim of the presented work was to predict theophylline pharmacokinetics (PK) after incorporating the changes in plasma albumin concentration occurring in patients with asthma into a physiologically based pharmacokinetic (PBPK) model to see whether these changes can affect the systemic theophylline concentrations in asthma. The PBPK model was developed following a systematic model building approach using Simcyp. The predictions were performed initially in healthy adults after intravenous and oral drug administration. Only when the developed adult PBPK model had adequately predicted theophylline PK in healthy adults, the changes in plasma albumin concentrations were incorporated into the model for predicting drug exposure in patients with asthma. After evaluation of the developed model in the adult population, it was scaled to children on physiologic basis. The model evaluation was performed by using visual predictive checks and comparison of ratio of observed and predicted (Robs/Pre) PK parameters along with their 2-fold error range. The developed PBPK model has effectively described theophylline PK in both healthy and diseased populations, as Robs/Pre for all the PK parameters were within the 2-fold error limit. The predictions in patients with asthma showed that there were no significant changes in PK parameters after incorporating the changes in serum albumin concentration. The mechanistic nature of the developed asthma-PBPK model can facilitate its extension to other drugs. SIGNIFICANCE STATEMENT: Exposure of a low hepatic clearance drug like theophylline may be susceptible to plasma albumin concentration changes that occur in asthma. These changes in systemic albumin concentrations can be incorporated into a physiologically based pharmacokinetic model to predict theophylline pharmacokinetics in adult and pediatric asthma populations. The presented work is focused on predicting theophylline absorption, distribution, metabolism, and elimination in adult and pediatric asthma populations after incorporating reported changes in serum albumin concentrations to see their impact on the systemic theophylline concentrations. SN - 1521-009X UR - https://www.unboundmedicine.com/medline/citation/32393652/Investigating_the_Role_of_Altered_Systemic_Albumin_Concentration_on_the_Disposition_of_Theophylline_in_Adult_and_Pediatric_Patients_with_Asthma_by_Using_the_Physiologically_Based_Pharmacokinetic_Approach_ DB - PRIME DP - Unbound Medicine ER -